NANOMETRICS INC 4

4 · NANOMETRICS INC · Filed Feb 19, 2014

Insider Transaction Report

Form 4

Period: 2014-02-14

NANOMETRICS INCNANO

Crawford Bruce A

Chief Operating Officer

Transactions

Sale
Common Stock
2014-02-14$18.63/sh−14,686$273,600→ 42,525 total
Tax Payment
Common Stock
2014-02-17$18.70/sh−1,388$25,956→ 41,137 total
Exercise/Conversion
Common Stock
2014-02-18$7.50/sh+3,443$25,823→ 46,247 total
Sale
Common Stock
2014-02-18$18.52/sh−26,278$486,669→ 33,264 total
Exercise/Conversion
Common Stock
2014-02-19$15.85/sh+3,333$52,828→ 37,157 total
Sale
Common Stock
2014-02-19$18.42/sh−3,893$71,709→ 33,264 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2014-02-18−12,500→ 0 total
Exercise: $13.08Exp: 2016-11-17→ Common Stock (12,500 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2014-02-19−560→ 16,250 total
Exercise: $11.37Exp: 2017-11-15→ Common Stock (560 underlying)
Exercise/Conversion
Common Stock
2014-02-18$1.17/sh+1,667$1,950→ 42,804 total
Exercise/Conversion
Common Stock
2014-02-18$11.37/sh+795$9,039→ 59,542 total
Exercise/Conversion
Common Stock
2014-02-19$11.37/sh+560$6,367→ 33,824 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2014-02-18−3,443→ 0 total
Exercise: $7.50Exp: 2016-09-03→ Common Stock (3,443 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2014-02-18−795→ 16,810 total
Exercise: $11.37Exp: 2017-11-15→ Common Stock (795 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2014-02-19−3,333→ 16,667 total
Exercise: $15.85Exp: 2020-03-12→ Common Stock (3,333 underlying)
Exercise/Conversion
Common Stock
2014-02-18$13.08/sh+12,500$163,500→ 58,747 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2014-02-18−1,667→ 0 total
Exercise: $1.17Exp: 2016-02-25→ Common Stock (1,667 underlying)

Footnotes (10)

[F1]Transaction pursuant to Rule 10b5-1 Plan adopted December 13, 2013.
[F10]One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (March 12, 2013).
[F2]Represents weighted average sales price. The shares were sold at prices ranging from $18.45 to $18.84. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F3]Represents weighted average sales price. The shares were sold at prices ranging from $18.40 to $18.70. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F4]Represents weighted average sales price. The shares were sold at prices ranging from $18.28 to $18.58. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F5]One thirty-sixth (1/36th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (February 25, 2009).
[F6]One third (1/3rd) of the shares are fully vested on the date of grant, with the remaining shares vesting (starting on the one year anniversary of the date of grant) at a rate of one twenty-fourth (1/24th) per month until fully vested on September 3, 2012.
[F7]One thirty-sixth (1/36th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 17, 2009).
[F8]One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 16, 2010).
[F9]One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 16, 2010).

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION